BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takahashi Y, Ikeda N, Nakajima J, Sawabata N, Chida M, Horio H, Okumura S, Kawamura M;  Metastatic Lung Tumor Study Group of Japan. Prognostic Analysis of Surgical Resection for Pulmonary Metastasis from Hepatocellular Carcinoma. World J Surg. 2016;40:2178-2185. [PMID: 27255943 DOI: 10.1007/s00268-016-3580-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen JY, Liu LP, Xu JF. Prognostic value of increased expression of RACO-1 in patients with hepatitis B-related hepatocellular carcinoma. Ther Clin Risk Manag 2017;13:191-200. [PMID: 28243109 DOI: 10.2147/TCRM.S125331] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Shigenobu T, Takahashi Y, Masugi Y, Hanawa R, Matsushita H, Tajima A, Kuroda H. Micropapillary Predominance Is a Risk Factor for Brain Metastasis in Resected Lung Adenocarcinoma. Clin Lung Cancer 2021:S1525-7304(21)00085-1. [PMID: 33992533 DOI: 10.1016/j.cllc.2021.04.001] [Reference Citation Analysis]
3 Takahashi Y, Suzuki S, Hamada K, Nakada T, Oya Y, Sakakura N, Matsushita H, Kuroda H. Sarcopenia is poor risk for unfavorable short- and long-term outcomes in stage I non-small cell lung cancer. Ann Transl Med 2021;9:325. [PMID: 33708952 DOI: 10.21037/atm-20-4380] [Reference Citation Analysis]
4 Wang L, Ye G, Zhan C, Sun F, Lin Z, Jiang W, Wang Q. Clinical Factors Predictive of a Better Prognosis of Pulmonary Metastasectomy for Hepatocellular Carcinoma. Ann Thorac Surg. 2019;108:1685-1691. [PMID: 31445050 DOI: 10.1016/j.athoracsur.2019.06.086] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
5 Yuan Z, Liu B, Hu C, Li Z, Zheng J, Li W. Clinical outcomes of percutaneous thermal ablation for pulmonary metastases from hepatocellular carcinoma: a retrospective study. Int J Hyperthermia 2020;37:651-9. [PMID: 32546040 DOI: 10.1080/02656736.2020.1775899] [Reference Citation Analysis]
6 Nakamura A, Esaki M, Nakagawa K, Asakura K, Kishi Y, Nara S, Shimada K, Watanabe SI. Three risk factors for pulmonary metastasectomy in patients with hepatocellular carcinoma. Gen Thorac Cardiovasc Surg 2019;67:782-7. [PMID: 30820914 DOI: 10.1007/s11748-019-01082-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wang C, Yang L, Liang Z, Liu Y, Liu S. Long-Term Survival and Prognostic Factors of Pulmonary Metastasectomy in Liver Cancer: A Systematic Review and Meta-Analysis. World J Surg. 2018;42:2153-2163. [PMID: 29435629 DOI: 10.1007/s00268-017-4431-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
8 Zhou Y, Zhou X, Ma J, Zhang W, Yan Z, Luo J. Nomogram for Predicting the Prognosis of Patients with Hepatocellular Carcinoma Presenting with Pulmonary Metastasis. Cancer Manag Res 2021;13:2083-94. [PMID: 33688251 DOI: 10.2147/CMAR.S296020] [Reference Citation Analysis]
9 Midorikawa Y, Takayama T, Nakayama H, Moriguchi M, Aramaki O, Yamazaki S, Teramoto K, Yoshida N, Kobayashi N, Tsuji S, Higaki T. Favorable outcomes of surgical resection for extrahepatic recurrent hepatocellular carcinoma. Hepatol Res. 2020;50:978-984. [PMID: 32573905 DOI: 10.1111/hepr.13526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nakamura A, Takuwa T, Hashimoto M, Kuroda A, Nakamichi T, Matsumoto S, Kondo N, Kijima T, Yamakado K, Hasegawa S. Clinical Outcomes With Recurrence After Pleurectomy/Decortication for Malignant Pleural Mesothelioma. The Annals of Thoracic Surgery 2020;109:1537-43. [DOI: 10.1016/j.athoracsur.2019.11.048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
11 Kaiho T, Suzuki H, Yamamoto T, Morimoto J, Sakairi Y, Wada H, Nakajima T, Yoshino I. Surgical outcomes of pulmonary metastasis from hepatopancreatobiliary carcinomas: a comparison with pulmonary metastasis from colorectal carcinomas. Surg Today 2019;49:762-8. [PMID: 30859309 DOI: 10.1007/s00595-019-01794-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Mashiko T, Masuoka Y, Nakano A, Tsuruya K, Hirose S, Hirabayashi K, Kagawa T, Nakagohri T. Intussusception due to hematogenous metastasis of hepatocellular carcinoma to the small intestine: A case report. World J Gastroenterol 2020; 26(42): 6698-6705 [PMID: 33268957 DOI: 10.3748/wjg.v26.i42.6698] [Reference Citation Analysis]
13 Allaire M, Goumard C, Lim C, Le Cleach A, Wagner M, Scatton O. New frontiers in liver resection for hepatocellular carcinoma. JHEP Rep. 2020;2:100134. [PMID: 32695968 DOI: 10.1016/j.jhepr.2020.100134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Lee HP, Yun JK, Jung HS, Moon DH, Lee GD, Choi S, Kim YH, Kim DK, Park SI, Kim HR. Surgical outcomes of pulmonary metastasectomy in hepatocellular carcinoma patients according to approach method: thoracoscopic versus open approach. World J Surg Oncol 2021;19:33. [PMID: 33516218 DOI: 10.1186/s12957-021-02138-0] [Reference Citation Analysis]
15 Long HY, Huang TY, Xie XY, Long JT, Liu BX. Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis. World J Clin Cases 2021; 9(21): 5754-5768 [PMID: 34368295 DOI: 10.12998/wjcc.v9.i21.5754] [Reference Citation Analysis]
16 Hu Z, Li W, Huang P, Zhou Z, Xu J, Xu K, Wang J, Zhang H. Therapeutic significance and indications of pulmonary metastasectomy for hepatocellular carcinoma following liver resection. International Journal of Surgery 2017;48:23-31. [DOI: 10.1016/j.ijsu.2017.09.075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
17 Jeong YH, Hwang S, Lee GD, Choi SH, Kim HR, Kim YH, Park SI, Kim DK. Surgical Outcome of Pulmonary Metastasectomy for Hepatocellular Carcinoma Recurrence in Liver Transplant Patients. Ann Transplant 2021;26:e930383. [PMID: 33972494 DOI: 10.12659/AOT.930383] [Reference Citation Analysis]
18 Wu C, Ren X, Zhang Q. Incidence, risk factors, and prognosis in patients with primary hepatocellular carcinoma and lung metastasis: a population-based study. Cancer Manag Res 2019;11:2759-68. [PMID: 31040715 DOI: 10.2147/CMAR.S192896] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
19 Ye G, Wang L, Hu Z, Liang J, Bian Y, Zhan C, Lin Z. Risk and prognostic nomograms for hepatocellular carcinoma with newly-diagnosed pulmonary metastasis using SEER data. PeerJ 2019;7:e7496. [PMID: 31440435 DOI: 10.7717/peerj.7496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Kuo TM, Chang KM, Cheng TI, Kao KJ. Clinical Factors Predicting Better Survival Outcome for Pulmonary Metastasectomy of Hepatocellular Carcinoma. Liver Cancer. 2017;6:297-306. [PMID: 29234633 DOI: 10.1159/000477134] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
21 Jin K, Wang K, Zhang H, Pan Y, Cao D, Wang M, Chen J, Wu D, Chen B, Xie X. Solitary Pulmonary Lesion in Patients with History of Malignancy: Primary Lung Cancer or Metastatic Cancer? Ann Surg Oncol 2018;25:1237-44. [PMID: 29417404 DOI: 10.1245/s10434-018-6360-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]